Hunan Er-Kang Pharmaceutical Co., Ltd (SHE:300267)
China flag China · Delayed Price · Currency is CNY
3.740
+0.090 (2.47%)
Feb 3, 2026, 3:04 PM CST

SHE:300267 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
709.2698.54744.35764.67761.56883.22
Short-Term Investments
-----400
Trading Asset Securities
901200.12114.12-5.3
Cash & Short-Term Investments
799.2818.54744.47878.79761.561,289
Cash Growth
4.01%9.95%-15.28%15.39%-40.90%-5.94%
Accounts Receivable
204.59198.3177.8204.48274.36422.08
Other Receivables
3.764.4618.1727.8113.574.48
Receivables
208.35202.77195.97232.29287.93426.56
Inventory
574.29600.78691.6821.34714.77756.06
Prepaid Expenses
--1.39---
Other Current Assets
192.229597.58158.78182.1214.63
Total Current Assets
1,7741,7171,7312,0911,9462,686
Property, Plant & Equipment
2,6782,7162,9172,8572,6043,026
Long-Term Investments
121.9121.74170.23188.97196.16155.96
Goodwill
22210.0110.0123.84
Other Intangible Assets
348.59363.56378.03406.14431.45553.35
Long-Term Deferred Tax Assets
148.14150.55152.14168.92118.3458.97
Long-Term Deferred Charges
10.2710.6612.0819.516.5113.96
Other Long-Term Assets
119.86117.78116.25114.6108.75138.93
Total Assets
5,2035,2005,4795,8565,4326,657
Accounts Payable
108.44114.66122.3198.7137.87152.23
Accrued Expenses
8.9926.0931.2223.3833.7924.66
Short-Term Debt
484.03488.2341.89396.64246463
Current Portion of Leases
8.93.692.164.113.88-
Current Income Taxes Payable
2.570.170.990.970.745.03
Current Unearned Revenue
37.929.8247.0151.3137.3533.89
Other Current Liabilities
41.4842.7157.7350.3339.376.97
Total Current Liabilities
692.31705.34603.3725.43498.93755.78
Long-Term Leases
27.6517.381.172.582.15-
Long-Term Unearned Revenue
11.2614.9318.3923.1527.9134.01
Long-Term Deferred Tax Liabilities
46.4346.946.253.4129.2929.05
Other Long-Term Liabilities
12.9912.99----
Total Liabilities
790.63797.54669.05804.57558.28818.84
Common Stock
2,0632,0632,0632,0632,0632,063
Additional Paid-In Capital
1,0191,0191,0191,005998.961,024
Retained Earnings
1,3441,3041,6771,9351,8892,783
Comprehensive Income & Other
43.8761.2776.5248.34-99.15-58.39
Total Common Equity
4,4704,4474,8365,0514,8515,811
Minority Interest
-57.56-45.23-26.030.2722.4927.11
Shareholders' Equity
4,4124,4024,8105,0514,8745,838
Total Liabilities & Equity
5,2035,2005,4795,8565,4326,657
Total Debt
520.57509.27345.21403.33252.04463
Net Cash (Debt)
278.63309.27399.25475.46509.53825.53
Net Cash Growth
-23.05%-22.54%-16.03%-6.69%-38.28%-39.74%
Net Cash Per Share
0.140.150.190.230.250.40
Filing Date Shares Outstanding
2,0632,0632,0632,0632,0632,063
Total Common Shares Outstanding
2,0632,0632,0632,0632,0632,063
Working Capital
1,0821,0121,1281,3661,4471,930
Book Value Per Share
2.172.162.342.452.352.82
Tangible Book Value
4,1194,0824,4564,6354,4105,234
Tangible Book Value Per Share
2.001.982.162.252.142.54
Buildings
-1,9331,9901,9261,7402,035
Machinery
-1,9141,8781,8961,2241,447
Construction In Progress
-174.58220.8952.92506.18408.21
Source: S&P Global Market Intelligence. Standard template. Financial Sources.